| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coactivator activity | 7.86e-08 | 303 | 52 | 9 | GO:0003713 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | MYT1L TRERF1 SS18L1 NCOA1 EWSR1 FUS ZMIZ1 RUNX1T1 ARID1A SS18 EP300 | 1.69e-07 | 562 | 52 | 11 | GO:0003712 |
| GeneOntologyMolecularFunction | molecular adaptor activity | MYT1L TRERF1 YTHDF1 TIAL1 SS18L1 EIF4G1 NCOA1 EWSR1 FUS ZMIZ1 RUNX1T1 ARID1A SS18 CAPRIN1 EP300 TAB3 | 1.88e-07 | 1356 | 52 | 16 | GO:0060090 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | MYT1L TRERF1 YTHDF1 TIAL1 SS18L1 NCOA1 EWSR1 FUS ZMIZ1 RUNX1T1 ARID1A SS18 CAPRIN1 EP300 | 1.02e-06 | 1160 | 52 | 14 | GO:0030674 |
| GeneOntologyMolecularFunction | mRNA binding | YTHDF1 CASC3 ILF3 TIAL1 SUPT5H RC3H1 EIF4G1 DAZL FUS DAZ3 CAPRIN1 | 1.36e-06 | 694 | 52 | 11 | GO:0003729 |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 1.91e-05 | 61 | 52 | 4 | GO:0030374 | |
| GeneOntologyMolecularFunction | mRNA 3'-UTR binding | 7.89e-05 | 276 | 52 | 6 | GO:0003730 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | 1.24e-04 | 187 | 52 | 5 | GO:0016922 | |
| GeneOntologyMolecularFunction | zinc ion binding | 4.40e-04 | 891 | 52 | 9 | GO:0008270 | |
| GeneOntologyMolecularFunction | translation activator activity | 6.83e-04 | 15 | 52 | 2 | GO:0008494 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 8.62e-04 | 1189 | 52 | 10 | GO:0046914 | |
| GeneOntologyMolecularFunction | SMAD binding | 1.46e-03 | 86 | 52 | 3 | GO:0046332 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring compression resistance | 1.62e-03 | 23 | 52 | 2 | GO:0030021 | |
| GeneOntologyMolecularFunction | nuclear retinoid X receptor binding | 1.62e-03 | 23 | 52 | 2 | GO:0046965 | |
| GeneOntologyMolecularFunction | protein-RNA adaptor activity | 1.77e-03 | 24 | 52 | 2 | GO:0140517 | |
| GeneOntologyMolecularFunction | mRNA 3'-UTR AU-rich region binding | 2.58e-03 | 29 | 52 | 2 | GO:0035925 | |
| GeneOntologyMolecularFunction | translation regulator activity, nucleic acid binding | 3.11e-03 | 112 | 52 | 3 | GO:0090079 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | 3.90e-03 | 582 | 52 | 6 | GO:0140297 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 4.50e-03 | 417 | 52 | 5 | GO:0061629 | |
| GeneOntologyMolecularFunction | molecular condensate scaffold activity | 5.36e-03 | 42 | 52 | 2 | GO:0140693 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 7.82e-03 | 51 | 52 | 2 | GO:0004402 | |
| GeneOntologyBiologicalProcess | regulation of translation | 3.55e-06 | 494 | 52 | 9 | GO:0006417 | |
| GeneOntologyBiologicalProcess | mRNA catabolic process | 3.99e-06 | 373 | 52 | 8 | GO:0006402 | |
| GeneOntologyBiologicalProcess | regulation of catabolic process | YTHDF1 CASC3 SUPT5H USP9X RC3H1 EIF4G1 SNX18 DAZL FUS DAZ3 CAPRIN1 EP300 TAB3 | 9.80e-06 | 1252 | 52 | 13 | GO:0009894 |
| GeneOntologyBiologicalProcess | RNA catabolic process | 1.17e-05 | 432 | 52 | 8 | GO:0006401 | |
| GeneOntologyBiologicalProcess | regulation of mRNA catabolic process | 1.19e-05 | 309 | 52 | 7 | GO:0061013 | |
| GeneOntologyBiologicalProcess | regulation of mRNA metabolic process | 1.40e-05 | 443 | 52 | 8 | GO:1903311 | |
| GeneOntologyBiologicalProcess | nucleic acid catabolic process | 1.95e-05 | 464 | 52 | 8 | GO:0141188 | |
| GeneOntologyBiologicalProcess | post-transcriptional regulation of gene expression | YTHDF1 CASC3 ILF3 TIAL1 RC3H1 EIF4G1 WT1 DAZL FUS DAZ3 CAPRIN1 EP300 | 2.26e-05 | 1153 | 52 | 12 | GO:0010608 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | MYT1L TRERF1 TET2 FLI1 SUPT5H SS18L1 WT1 NCOA1 ZMIZ1 ABLIM3 SS18 EP300 NPAS2 | 2.98e-05 | 1390 | 52 | 13 | GO:0045944 |
| GeneOntologyBiologicalProcess | positive regulation of translation | 3.88e-05 | 151 | 52 | 5 | GO:0045727 | |
| GeneOntologyBiologicalProcess | positive regulation of translational initiation | 5.27e-05 | 29 | 52 | 3 | GO:0045948 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound catabolic process | 5.40e-05 | 696 | 52 | 9 | GO:0034655 | |
| GeneOntologyBiologicalProcess | negative regulation of catabolic process | 8.13e-05 | 418 | 52 | 7 | GO:0009895 | |
| GeneOntologyBiologicalProcess | regulation of translational initiation | 8.16e-05 | 91 | 52 | 4 | GO:0006446 | |
| GeneOntologyBiologicalProcess | mRNA metabolic process | 8.30e-05 | 917 | 52 | 10 | GO:0016071 | |
| GeneOntologyBiologicalProcess | regulation of mRNA stability | 9.01e-05 | 292 | 52 | 6 | GO:0043488 | |
| GeneOntologyBiologicalProcess | female meiosis II | 9.29e-05 | 6 | 52 | 2 | GO:0007147 | |
| GeneOntologyBiologicalProcess | meiosis II | 9.29e-05 | 6 | 52 | 2 | GO:0007135 | |
| GeneOntologyBiologicalProcess | meiosis II cell cycle process | 9.29e-05 | 6 | 52 | 2 | GO:0061983 | |
| GeneOntologyBiologicalProcess | regulation of RNA stability | 1.21e-04 | 308 | 52 | 6 | GO:0043487 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 1.53e-04 | 202 | 52 | 5 | GO:0141193 | |
| GeneOntologyBiologicalProcess | cardiac muscle tissue development | 1.67e-04 | 327 | 52 | 6 | GO:0048738 | |
| GeneOntologyBiologicalProcess | translation | 1.95e-04 | 824 | 52 | 9 | GO:0006412 | |
| GeneOntologyBiologicalProcess | amyloid fibril formation | 1.99e-04 | 45 | 52 | 3 | GO:1990000 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 2.02e-04 | 115 | 52 | 4 | GO:1903312 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 2.13e-04 | 46 | 52 | 3 | GO:0000184 | |
| GeneOntologyBiologicalProcess | striated muscle tissue development | 2.37e-04 | 349 | 52 | 6 | GO:0014706 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | ENAM TET2 FLI1 HSPG2 ADAMTS9 SEC24B WT1 ZMIZ1 ARID1A EP300 NDRG4 | 2.67e-04 | 1269 | 52 | 11 | GO:0009887 |
| GeneOntologyBiologicalProcess | androgen receptor signaling pathway | 2.89e-04 | 51 | 52 | 3 | GO:0030521 | |
| GeneOntologyBiologicalProcess | nuclear-transcribed mRNA catabolic process | 3.42e-04 | 132 | 52 | 4 | GO:0000956 | |
| GeneOntologyBiologicalProcess | translational initiation | 3.42e-04 | 132 | 52 | 4 | GO:0006413 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 3.67e-04 | 244 | 52 | 5 | GO:0009755 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated steroid hormone signaling pathway | 3.83e-04 | 136 | 52 | 4 | GO:0030518 | |
| GeneOntologyBiologicalProcess | behavioral defense response | 4.45e-04 | 59 | 52 | 3 | GO:0002209 | |
| GeneOntologyBiologicalProcess | heart development | 5.71e-04 | 757 | 52 | 8 | GO:0007507 | |
| GeneOntologyBiologicalProcess | transcription initiation-coupled chromatin remodeling | 5.91e-04 | 65 | 52 | 3 | GO:0045815 | |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | 6.03e-04 | 416 | 52 | 6 | GO:0030522 | |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 6.27e-04 | 155 | 52 | 4 | GO:0043401 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression, epigenetic | 6.75e-04 | 68 | 52 | 3 | GO:0141137 | |
| GeneOntologyBiologicalProcess | endoplasmic reticulum to Golgi vesicle-mediated transport | 6.90e-04 | 159 | 52 | 4 | GO:0006888 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | YTHDF1 ENAM HSPG2 USP9X SS18L1 LRATD1 SEC24B SS18 CAPRIN1 EP300 | 6.94e-04 | 1194 | 52 | 10 | GO:0000902 |
| GeneOntologyBiologicalProcess | neuron development | MYT1L YTHDF1 HSPG2 USP9X SS18L1 SEC24B LTK ZMIZ1 CAPRIN1 EP300 NDRG4 | 8.89e-04 | 1463 | 52 | 11 | GO:0048666 |
| GeneOntologyBiologicalProcess | intracellular mRNA localization | 9.29e-04 | 18 | 52 | 2 | GO:0008298 | |
| GeneOntologyBiologicalProcess | mRNA stabilization | 9.69e-04 | 77 | 52 | 3 | GO:0048255 | |
| GeneOntologyCellularComponent | cytoplasmic stress granule | 1.37e-07 | 96 | 52 | 6 | GO:0010494 | |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 3.55e-06 | 42 | 52 | 4 | GO:0070971 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 5.32e-05 | 269 | 52 | 6 | GO:0036464 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 7.61e-05 | 287 | 52 | 6 | GO:0035770 | |
| GeneOntologyCellularComponent | npBAF complex | 5.42e-04 | 14 | 52 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | nBAF complex | 7.12e-04 | 16 | 52 | 2 | GO:0071565 | |
| GeneOntologyCellularComponent | exon-exon junction complex | 1.24e-03 | 21 | 52 | 2 | GO:0035145 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 1.76e-03 | 96 | 52 | 3 | GO:0070603 | |
| GeneOntologyCellularComponent | P-body | 2.10e-03 | 102 | 52 | 3 | GO:0000932 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 2.52e-03 | 30 | 52 | 2 | GO:0016514 | |
| GeneOntologyCellularComponent | COPII-coated ER to Golgi transport vesicle | 2.60e-03 | 110 | 52 | 3 | GO:0030134 | |
| HumanPheno | Cachexia | 2.47e-05 | 100 | 19 | 5 | HP:0004326 | |
| HumanPheno | Wide nasal base | 1.36e-04 | 28 | 19 | 3 | HP:0012810 | |
| HumanPheno | Abnormal nasal base norphology | 1.68e-04 | 30 | 19 | 3 | HP:0012808 | |
| HumanPheno | Low weight | 1.80e-04 | 627 | 19 | 9 | HP:0001823 | |
| HumanPheno | Feeding difficulties | MYT1L FLI1 HSPG2 B4GALNT1 EIF4G1 FUS ZMIZ1 ARID1A TFG CAPRIN1 EP300 | 2.13e-04 | 982 | 19 | 11 | HP:0002022 |
| HumanPheno | Disinhibition | MYT1L FLI1 HSPG2 USP9X EIF4G1 FUS ZMIZ1 ARID1A CAPRIN1 EP300 | 2.22e-04 | 807 | 19 | 10 | HP:0000734 |
| HumanPheno | Inappropriate behavior | MYT1L FLI1 HSPG2 USP9X EIF4G1 FUS ZMIZ1 ARID1A CAPRIN1 EP300 | 2.22e-04 | 807 | 19 | 10 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | MYT1L FLI1 HSPG2 USP9X EIF4G1 FUS ZMIZ1 ARID1A CAPRIN1 EP300 | 2.22e-04 | 807 | 19 | 10 | HP:5200123 |
| HumanPheno | Social disinhibition | MYT1L FLI1 HSPG2 USP9X EIF4G1 FUS ZMIZ1 ARID1A CAPRIN1 EP300 | 2.22e-04 | 807 | 19 | 10 | HP:5200029 |
| HumanPheno | Aggressive behavior | 2.89e-04 | 516 | 19 | 8 | HP:0000718 | |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | 2.89e-04 | 516 | 19 | 8 | HP:0006919 | |
| HumanPheno | Typified by somatic mosaicism | 2.94e-04 | 168 | 19 | 5 | HP:0001442 | |
| HumanPheno | Somatic mutation | 2.94e-04 | 168 | 19 | 5 | HP:0001428 | |
| HumanPheno | Neoplasm of the male external genitalia | 3.16e-04 | 37 | 19 | 3 | HP:0100848 | |
| HumanPheno | Weight loss | 3.17e-04 | 388 | 19 | 7 | HP:0001824 | |
| HumanPheno | Reduced impulse control | MYT1L TET2 FLI1 HSPG2 USP9X EIF4G1 FUS ZMIZ1 ARID1A CAPRIN1 EP300 | 3.39e-04 | 1032 | 19 | 11 | HP:5200045 |
| HumanPheno | Neoplasm of the central nervous system | 3.84e-04 | 178 | 19 | 5 | HP:0100006 | |
| HumanPheno | Abnormal columella morphology | 3.85e-04 | 97 | 19 | 4 | HP:0009929 | |
| HumanPheno | Abnormally increased volition | MYT1L FLI1 HSPG2 USP9X EIF4G1 FUS ZMIZ1 ARID1A CAPRIN1 EP300 | 4.16e-04 | 869 | 19 | 10 | HP:5200263 |
| HumanPheno | Functional abnormality of the gastrointestinal tract | MYT1L TET2 HSPG2 B4GALNT1 USP9X EIF4G1 WT1 EWSR1 FUS TFG CAPRIN1 EP300 | 4.59e-04 | 1270 | 19 | 12 | HP:0012719 |
| HumanPheno | Recurrent maladaptive behavior | MYT1L TET2 FLI1 HSPG2 B4GALNT1 USP9X EIF4G1 FUS ZMIZ1 ARID1A CAPRIN1 EP300 | 5.49e-04 | 1293 | 19 | 12 | HP:5200241 |
| HumanPheno | Neoplasm of the nervous system | 5.86e-04 | 195 | 19 | 5 | HP:0004375 | |
| HumanPheno | Gonadal neoplasm | 6.00e-04 | 109 | 19 | 4 | HP:0010785 | |
| HumanPheno | Abnormal social development | MYT1L FLI1 HSPG2 USP9X EIF4G1 FUS ZMIZ1 ARID1A CAPRIN1 EP300 | 6.00e-04 | 908 | 19 | 10 | HP:0025732 |
| HumanPheno | Single umbilical artery | 6.04e-04 | 46 | 19 | 3 | HP:0001195 | |
| HumanPheno | Abnormal umbilical cord blood vessel morphology | 6.04e-04 | 46 | 19 | 3 | HP:0011403 | |
| MousePheno | abnormal prenatal body size | FLI1 CASC3 HSPG2 TIAL1 ADAMTS9 USP9X SEC24B WT1 FUS ZMIZ1 ARID1A CAPRIN1 EP300 | 4.20e-05 | 1116 | 46 | 13 | MP:0010866 |
| MousePheno | abnormal embryo size | FLI1 CASC3 HSPG2 TIAL1 ADAMTS9 USP9X SEC24B WT1 FUS ZMIZ1 ARID1A EP300 | 4.33e-05 | 956 | 46 | 12 | MP:0001697 |
| MousePheno | abnormal embryonic growth/weight/body size | FLI1 CASC3 HSPG2 TIAL1 ADAMTS9 USP9X SEC24B WT1 FUS ZMIZ1 ARID1A SS18 EP300 SMG6 | 4.48e-05 | 1295 | 46 | 14 | MP:0002088 |
| MousePheno | abnormal prenatal growth/weight/body size | FLI1 CASC3 HSPG2 TIAL1 ADAMTS9 USP9X SEC24B WT1 FUS ZMIZ1 ARID1A SS18 CAPRIN1 EP300 SMG6 | 5.16e-05 | 1493 | 46 | 15 | MP:0004196 |
| Domain | SSXT | 2.28e-05 | 3 | 52 | 2 | PF05030 | |
| Domain | SS18_fam | 2.28e-05 | 3 | 52 | 2 | IPR007726 | |
| Domain | zf-RanBP | 3.02e-05 | 22 | 52 | 3 | PF00641 | |
| Domain | ZnF_RBZ | 3.47e-05 | 23 | 52 | 3 | SM00547 | |
| Domain | ZF_RANBP2_2 | 3.47e-05 | 23 | 52 | 3 | PS50199 | |
| Domain | ZF_RANBP2_1 | 3.95e-05 | 24 | 52 | 3 | PS01358 | |
| Domain | Znf_RanBP2 | 4.48e-05 | 25 | 52 | 3 | IPR001876 | |
| Domain | Nuc_rcpt_coact | 1.13e-04 | 6 | 52 | 2 | IPR009110 | |
| Domain | RRM_1 | 2.77e-04 | 208 | 52 | 5 | PF00076 | |
| Domain | RRM | 3.37e-04 | 217 | 52 | 5 | SM00360 | |
| Domain | - | 3.37e-04 | 10 | 52 | 2 | 4.10.1060.10 | |
| Domain | RRM_dom | 4.14e-04 | 227 | 52 | 5 | IPR000504 | |
| Domain | RRM | 4.40e-04 | 230 | 52 | 5 | PS50102 | |
| Domain | - | 5.75e-04 | 244 | 52 | 5 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 7.40e-04 | 258 | 52 | 5 | IPR012677 | |
| Domain | PAS | 2.19e-03 | 25 | 52 | 2 | PF00989 | |
| Domain | PAS_fold | 2.19e-03 | 25 | 52 | 2 | IPR013767 | |
| Domain | PAS | 3.57e-03 | 32 | 52 | 2 | SM00091 | |
| Domain | PAS | 4.03e-03 | 34 | 52 | 2 | IPR000014 | |
| Domain | PAS | 4.03e-03 | 34 | 52 | 2 | PS50112 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 5.49e-05 | 24 | 44 | 3 | M13404 | |
| Pubmed | TRERF1 YTHDF1 TET2 FLI1 HSPG2 USP9X RC3H1 SS18L1 SEC24B EIF4G1 NCOA1 EWSR1 ZMIZ1 ARID1A SS18 ERBIN CAPRIN1 EP300 TAB3 | 8.53e-14 | 1429 | 52 | 19 | 35140242 | |
| Pubmed | 7.07e-11 | 152 | 52 | 8 | 38360978 | ||
| Pubmed | FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex. | 2.02e-10 | 23 | 52 | 5 | 30962207 | |
| Pubmed | 1.20e-09 | 32 | 52 | 5 | 19542561 | ||
| Pubmed | 7.47e-09 | 274 | 52 | 8 | 34244482 | ||
| Pubmed | 1.19e-08 | 421 | 52 | 9 | 34650049 | ||
| Pubmed | Characterization of TFG in mus musculus and Caenorhabditis elegans. | 1.26e-08 | 4 | 52 | 3 | 10092511 | |
| Pubmed | TRERF1 CASC3 ILF3 USP9X SEC23IP EIF4G1 EWSR1 FUS ABLIM3 ERBIN CAPRIN1 SMG6 | 1.41e-08 | 963 | 52 | 12 | 28671696 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 2.41e-08 | 457 | 52 | 9 | 32344865 | |
| Pubmed | IGF1 is a common target gene of Ewing's sarcoma fusion proteins in mesenchymal progenitor cells. | 3.15e-08 | 5 | 52 | 3 | 18648544 | |
| Pubmed | YTHDF1 HSPG2 ILF3 USP9X BAG4 SEC24B EIF4G1 PYGB EWSR1 FUS TFG | 3.93e-08 | 844 | 52 | 11 | 25963833 | |
| Pubmed | 4.68e-08 | 494 | 52 | 9 | 26831064 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 5.08e-08 | 351 | 52 | 8 | 38297188 | |
| Pubmed | TRERF1 TET2 FLI1 ILF3 TIAL1 WT1 NCOA1 EWSR1 FUS ARID1A CAPRIN1 EP300 | 6.24e-08 | 1103 | 52 | 12 | 34189442 | |
| Pubmed | Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. | 6.28e-08 | 6 | 52 | 3 | 18509338 | |
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 1.15e-07 | 258 | 52 | 7 | 37794589 | |
| Pubmed | 1.18e-07 | 551 | 52 | 9 | 34728620 | ||
| Pubmed | 2.63e-07 | 9 | 52 | 3 | 20159962 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 2.81e-07 | 807 | 52 | 10 | 22681889 | |
| Pubmed | 3.04e-07 | 298 | 52 | 7 | 30737378 | ||
| Pubmed | MYT1L TET2 ADAMTS9 SUPT5H USP9X SCG2 SEC23IP EIF4G1 EWSR1 ARID1A CAPRIN1 EP300 | 3.23e-07 | 1285 | 52 | 12 | 35914814 | |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | 4.12e-07 | 462 | 52 | 8 | 31138677 | |
| Pubmed | 5.84e-07 | 484 | 52 | 8 | 31995728 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | FLI1 TIAL1 SUPT5H SS18L1 WT1 EWSR1 RUNX1T1 ZNF496 EP300 NPAS2 | 5.99e-07 | 877 | 52 | 10 | 20211142 |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | 6.72e-07 | 678 | 52 | 9 | 30209976 | |
| Pubmed | Licensing of primordial germ cells for gametogenesis depends on genital ridge signaling. | 6.87e-07 | 12 | 52 | 3 | 25739037 | |
| Pubmed | PRMT7 is involved in regulation of germ cell proliferation during embryonic stage. | 8.92e-07 | 13 | 52 | 3 | 33008598 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | YTHDF1 CASC3 SUPT5H USP9X BAG4 SEC24B EIF4G1 NCOA1 EWSR1 TFG | 9.42e-07 | 922 | 52 | 10 | 27609421 |
| Pubmed | Regulation of the CUL3Â Ubiquitin Ligase by a Calcium-Dependent Co-adaptor. | 9.72e-07 | 50 | 52 | 4 | 27716508 | |
| Pubmed | 1.42e-06 | 15 | 52 | 3 | 23785148 | ||
| Pubmed | 1.50e-06 | 549 | 52 | 8 | 38280479 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 31392992 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 33051146 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 25057021 | ||
| Pubmed | DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma. | 2.19e-06 | 2 | 52 | 2 | 28134926 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 25482556 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 22086061 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 23145994 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 25453903 | ||
| Pubmed | Cancer-Specific Retargeting of BAF Complexes by a Prion-like Domain. | 2.19e-06 | 2 | 52 | 2 | 28844694 | |
| Pubmed | Epigenetic control of the EWS‑FLI1 promoter in Ewing's sarcoma. | 2.19e-06 | 2 | 52 | 2 | 32323788 | |
| Pubmed | Homotypic and heterotypic interactions of EWS, FLI1 and their oncogenic fusion protein. | 2.19e-06 | 2 | 52 | 2 | 14534527 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 28561686 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 8921363 | ||
| Pubmed | WT1 recruits TET2 to regulate its target gene expression and suppress leukemia cell proliferation. | 2.19e-06 | 2 | 52 | 2 | 25601757 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 24321497 | ||
| Pubmed | EWS-FLI1 in Ewing's sarcoma: real targets and collateral damage. | 2.19e-06 | 2 | 52 | 2 | 17163154 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 26573619 | ||
| Pubmed | Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma. | 2.19e-06 | 2 | 52 | 2 | 23178492 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 36357572 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 38158126 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 24735198 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 21643012 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 23441188 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 25591392 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 39062631 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 20660338 | ||
| Pubmed | Molecular analysis of a t(11;22) translocation junction in a case of Ewing's sarcoma. | 2.19e-06 | 2 | 52 | 2 | 7542907 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 25454478 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 11030627 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 36787739 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 12509448 | ||
| Pubmed | EWS/FLI is a Master Regulator of Metabolic Reprogramming in Ewing Sarcoma. | 2.19e-06 | 2 | 52 | 2 | 28720588 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 19417137 | ||
| Pubmed | Ablation of EWS-FLI1 by USP9X inhibition suppresses cancer cell growth in Ewing sarcoma. | 2.19e-06 | 2 | 52 | 2 | 36330954 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 24934812 | ||
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 39198430 | ||
| Pubmed | Common origin of the human synovial sarcoma associated SS18 and SS18L1 gene loci. | 2.19e-06 | 2 | 52 | 2 | 16484776 | |
| Pubmed | 2.19e-06 | 2 | 52 | 2 | 31994243 | ||
| Pubmed | Induction of the interleukin-2/15 receptor beta-chain by the EWS-WT1 translocation product. | 2.19e-06 | 2 | 52 | 2 | 11960373 | |
| Pubmed | Ewing sarcoma cells secrete EWS/Fli-1 fusion mRNA via microvesicles. | 2.19e-06 | 2 | 52 | 2 | 24124617 | |
| Pubmed | Precision medicine in Ewing sarcoma: a translational point of view. | 2.19e-06 | 2 | 52 | 2 | 32026343 | |
| Pubmed | 2.51e-06 | 260 | 52 | 6 | 36199071 | ||
| Pubmed | 2.53e-06 | 18 | 52 | 3 | 33323119 | ||
| Pubmed | 2.69e-06 | 263 | 52 | 6 | 34702444 | ||
| Pubmed | 2.81e-06 | 65 | 52 | 4 | 26655900 | ||
| Pubmed | 3.23e-06 | 425 | 52 | 7 | 24999758 | ||
| Pubmed | 3.47e-06 | 615 | 52 | 8 | 31048545 | ||
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 3.50e-06 | 154 | 52 | 5 | 16055720 | |
| Pubmed | 3.57e-06 | 69 | 52 | 4 | 32238831 | ||
| Pubmed | 3.79e-06 | 70 | 52 | 4 | 34255829 | ||
| Pubmed | 4.01e-06 | 282 | 52 | 6 | 23667531 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 4.05e-06 | 440 | 52 | 7 | 34244565 | |
| Pubmed | 4.76e-06 | 22 | 52 | 3 | 35120648 | ||
| Pubmed | DNA Methyltransferase 1 Controls Nephron Progenitor Cell Renewal and Differentiation. | 4.76e-06 | 22 | 52 | 3 | 30518531 | |
| Pubmed | 5.38e-06 | 653 | 52 | 8 | 22586326 | ||
| Pubmed | 6.46e-06 | 80 | 52 | 4 | 16094384 | ||
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 34009296 | ||
| Pubmed | Dendrite development regulated by CREST, a calcium-regulated transcriptional activator. | 6.57e-06 | 3 | 52 | 2 | 14716005 | |
| Pubmed | FUS-NFATC2 or EWSR1-NFATC2 Fusions Are Present in a Large Proportion of Simple Bone Cysts. | 6.57e-06 | 3 | 52 | 2 | 32991339 | |
| Pubmed | Chromosomal localization of Ewing sarcoma EWSR1/FLI1 protein promotes the induction of aneuploidy. | 6.57e-06 | 3 | 52 | 2 | 33293370 | |
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 18620564 | ||
| Pubmed | NR0B1 is required for the oncogenic phenotype mediated by EWS/FLI in Ewing's sarcoma. | 6.57e-06 | 3 | 52 | 2 | 17114343 | |
| Pubmed | The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. | 6.57e-06 | 3 | 52 | 2 | 8855229 | |
| Pubmed | EWS-FLI1 regulates a transcriptional program in cooperation with Foxq1 in mouse Ewing sarcoma. | 6.57e-06 | 3 | 52 | 2 | 29945296 | |
| Pubmed | Targeting the EWSR1-FLI1 oncogene-induced protein kinase PKC-β abolishes ewing sarcoma growth. | 6.57e-06 | 3 | 52 | 2 | 22930730 | |
| Pubmed | Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. | 6.57e-06 | 3 | 52 | 2 | 1522903 | |
| Pubmed | 6.57e-06 | 3 | 52 | 2 | 15282325 | ||
| Pubmed | The EWS/FLI1 oncogenic transcription factor deregulates GLI1. | 6.57e-06 | 3 | 52 | 2 | 18084326 | |
| Pubmed | mRNA and protein levels of FUS, EWSR1, and TAF15 are upregulated in liposarcoma. | 6.57e-06 | 3 | 52 | 2 | 21344536 | |
| Interaction | EYA4 interactions | 5.48e-10 | 243 | 52 | 10 | int:EYA4 | |
| Interaction | CRX interactions | 8.42e-10 | 254 | 52 | 10 | int:CRX | |
| Interaction | BRCA1 interactions | FLI1 ILF3 TIAL1 SUPT5H USP9X SEC24B SEC23IP EIF4G1 NCOA1 EWSR1 FUS ZMIZ1 RUNX1T1 ARID1A ABLIM3 TFG CAPRIN1 EP300 | 9.14e-10 | 1249 | 52 | 18 | int:BRCA1 |
| Interaction | TDRD3 interactions | 3.31e-09 | 212 | 52 | 9 | int:TDRD3 | |
| Interaction | SF1 interactions | 4.76e-09 | 304 | 52 | 10 | int:SF1 | |
| Interaction | FMR1 interactions | YTHDF1 CASC3 ILF3 TIAL1 USP9X RC3H1 EIF4G1 DAZL EWSR1 LTK CAPRIN1 SMG6 | 8.68e-09 | 536 | 52 | 12 | int:FMR1 |
| Interaction | FLI1 interactions | 1.21e-08 | 62 | 52 | 6 | int:FLI1 | |
| Interaction | SNRPA interactions | MYT1L YTHDF1 ILF3 TIAL1 SUPT5H RC3H1 BAG4 EWSR1 FUS LTK EP300 | 3.26e-08 | 482 | 52 | 11 | int:SNRPA |
| Interaction | ARID1A interactions | 3.27e-08 | 276 | 52 | 9 | int:ARID1A | |
| Interaction | SMARCC1 interactions | 4.35e-08 | 384 | 52 | 10 | int:SMARCC1 | |
| Interaction | SOX2 interactions | TRERF1 YTHDF1 TET2 FLI1 ILF3 TIAL1 SUPT5H USP9X SNX18 EWSR1 FUS ARID1A ABLIM3 SS18 CAPRIN1 EP300 SMG6 | 4.96e-08 | 1422 | 52 | 17 | int:SOX2 |
| Interaction | SEC24C interactions | 5.53e-08 | 207 | 52 | 8 | int:SEC24C | |
| Interaction | PRMT1 interactions | YTHDF1 TET2 ILF3 SUPT5H USP9X EIF4G1 NCOA1 DAZL EWSR1 FUS TFG CAPRIN1 EP300 TAB3 | 6.10e-08 | 929 | 52 | 14 | int:PRMT1 |
| Interaction | SP7 interactions | 7.48e-08 | 304 | 52 | 9 | int:SP7 | |
| Interaction | FAM168A interactions | 7.63e-08 | 142 | 52 | 7 | int:FAM168A | |
| Interaction | BMI1 interactions | YTHDF1 CASC3 ILF3 TIAL1 SS18L1 SEC24B SEC23IP EIF4G1 EWSR1 FUS CAPRIN1 EP300 | 8.42e-08 | 659 | 52 | 12 | int:BMI1 |
| Interaction | DAZL interactions | 8.81e-08 | 145 | 52 | 7 | int:DAZL | |
| Interaction | ERG interactions | 9.81e-08 | 223 | 52 | 8 | int:ERG | |
| Interaction | SS18 interactions | 1.01e-07 | 88 | 52 | 6 | int:SS18 | |
| Interaction | NUP35 interactions | 1.10e-07 | 424 | 52 | 10 | int:NUP35 | |
| Interaction | PABPC1 interactions | YTHDF1 TET2 CASC3 ILF3 TIAL1 RC3H1 EIF4G1 DAZL FUS CAPRIN1 EP300 SMG6 | 1.59e-07 | 699 | 52 | 12 | int:PABPC1 |
| Interaction | CPSF7 interactions | 1.84e-07 | 338 | 52 | 9 | int:CPSF7 | |
| Interaction | UPF1 interactions | YTHDF1 CASC3 ILF3 TIAL1 RC3H1 DAZL EWSR1 FUS CAPRIN1 EP300 SMG6 | 2.15e-07 | 581 | 52 | 11 | int:UPF1 |
| Interaction | EGR2 interactions | 2.72e-07 | 171 | 52 | 7 | int:EGR2 | |
| Interaction | IGF2BP1 interactions | YTHDF1 ILF3 MAN1A1 RC3H1 SEC24B SEC23IP DAZL FUS CAPRIN1 EP300 | 5.80e-07 | 508 | 52 | 10 | int:IGF2BP1 |
| Interaction | PRRC2A interactions | 5.99e-07 | 389 | 52 | 9 | int:PRRC2A | |
| Interaction | PSPC1 interactions | 6.57e-07 | 515 | 52 | 10 | int:PSPC1 | |
| Interaction | ETS1 interactions | 6.72e-07 | 121 | 52 | 6 | int:ETS1 | |
| Interaction | CELF1 interactions | 6.89e-07 | 288 | 52 | 8 | int:CELF1 | |
| Interaction | BICRA interactions | 8.04e-07 | 67 | 52 | 5 | int:BICRA | |
| Interaction | GCM1 interactions | 8.66e-07 | 68 | 52 | 5 | int:GCM1 | |
| Interaction | TAF15 interactions | 8.91e-07 | 408 | 52 | 9 | int:TAF15 | |
| Interaction | ETV4 interactions | 9.31e-07 | 69 | 52 | 5 | int:ETV4 | |
| Interaction | EIF4ENIF1 interactions | 9.36e-07 | 300 | 52 | 8 | int:EIF4ENIF1 | |
| Interaction | CNOT3 interactions | 9.85e-07 | 207 | 52 | 7 | int:CNOT3 | |
| Interaction | LARP4 interactions | 1.09e-06 | 210 | 52 | 7 | int:LARP4 | |
| Interaction | ATXN2 interactions | 1.26e-06 | 312 | 52 | 8 | int:ATXN2 | |
| Interaction | HDAC2 interactions | TET2 HSPG2 ILF3 SS18L1 LPP EWSR1 FUS RUNX1T1 ARID1A SS18 CAPRIN1 EP300 | 1.53e-06 | 865 | 52 | 12 | int:HDAC2 |
| Interaction | GLDC interactions | 1.55e-06 | 321 | 52 | 8 | int:GLDC | |
| Interaction | TRIM31 interactions | 2.15e-06 | 454 | 52 | 9 | int:TRIM31 | |
| Interaction | CAND1 interactions | CASC3 ILF3 TIAL1 USP9X BAG4 SEC24B PYGB EWSR1 FUS TFG CAPRIN1 EP300 | 2.16e-06 | 894 | 52 | 12 | int:CAND1 |
| Interaction | SOX7 interactions | 2.20e-06 | 82 | 52 | 5 | int:SOX7 | |
| Interaction | OTUD4 interactions | 2.36e-06 | 236 | 52 | 7 | int:OTUD4 | |
| Interaction | KLF1 interactions | 2.44e-06 | 37 | 52 | 4 | int:KLF1 | |
| Interaction | SF3B4 interactions | 2.49e-06 | 342 | 52 | 8 | int:SF3B4 | |
| Interaction | CREBBP interactions | 2.56e-06 | 599 | 52 | 10 | int:CREBBP | |
| Interaction | SMAD1 interactions | 2.86e-06 | 243 | 52 | 7 | int:SMAD1 | |
| Interaction | SMARCC2 interactions | 3.15e-06 | 353 | 52 | 8 | int:SMARCC2 | |
| Interaction | NCBP1 interactions | 3.15e-06 | 353 | 52 | 8 | int:NCBP1 | |
| Interaction | PHB1 interactions | CASC3 YIPF5 ILF3 TIAL1 BAG4 EIF4G1 EWSR1 FUS ARID1A TFG CAPRIN1 EP300 SMG6 | 3.87e-06 | 1123 | 52 | 13 | int:PHB1 |
| Interaction | DPF3 interactions | 4.57e-06 | 95 | 52 | 5 | int:DPF3 | |
| Interaction | UBAP2 interactions | 4.87e-06 | 170 | 52 | 6 | int:UBAP2 | |
| Interaction | DDX6 interactions | 4.96e-06 | 503 | 52 | 9 | int:DDX6 | |
| Interaction | PRRC2B interactions | 5.07e-06 | 265 | 52 | 7 | int:PRRC2B | |
| Interaction | SS18L1 interactions | 5.32e-06 | 98 | 52 | 5 | int:SS18L1 | |
| Interaction | DDX3X interactions | 5.36e-06 | 651 | 52 | 10 | int:DDX3X | |
| Interaction | MAPK1IP1L interactions | 5.43e-06 | 45 | 52 | 4 | int:MAPK1IP1L | |
| Interaction | MEX3A interactions | 5.84e-06 | 384 | 52 | 8 | int:MEX3A | |
| Interaction | RC3H2 interactions | 6.64e-06 | 667 | 52 | 10 | int:RC3H2 | |
| Interaction | CPSF6 interactions | 7.11e-06 | 526 | 52 | 9 | int:CPSF6 | |
| Interaction | ALG13 interactions | 7.43e-06 | 183 | 52 | 6 | int:ALG13 | |
| Interaction | AGO1 interactions | 7.43e-06 | 183 | 52 | 6 | int:AGO1 | |
| Interaction | RC3H1 interactions | 7.56e-06 | 677 | 52 | 10 | int:RC3H1 | |
| Interaction | EP300 interactions | TRERF1 CASC3 ILF3 SUPT5H USP9X SS18L1 SEC24B NCOA1 EWSR1 FUS ARID1A SS18 EP300 NPAS2 | 8.33e-06 | 1401 | 52 | 14 | int:EP300 |
| Interaction | SMARCE1 interactions | 8.54e-06 | 287 | 52 | 7 | int:SMARCE1 | |
| Interaction | ANKHD1-EIF4EBP3 interactions | 8.56e-06 | 108 | 52 | 5 | int:ANKHD1-EIF4EBP3 | |
| Interaction | PEF1 interactions | 8.56e-06 | 108 | 52 | 5 | int:PEF1 | |
| Interaction | PABPN1 interactions | 9.78e-06 | 192 | 52 | 6 | int:PABPN1 | |
| Interaction | MAGED1 interactions | 1.02e-05 | 295 | 52 | 7 | int:MAGED1 | |
| Interaction | FUBP3 interactions | 1.07e-05 | 297 | 52 | 7 | int:FUBP3 | |
| Interaction | TSG101 interactions | 1.21e-05 | 303 | 52 | 7 | int:TSG101 | |
| Interaction | RNF43 interactions | 1.27e-05 | 427 | 52 | 8 | int:RNF43 | |
| Interaction | CUL5 interactions | 1.30e-05 | 567 | 52 | 9 | int:CUL5 | |
| Interaction | PDCD6 interactions | 1.38e-05 | 204 | 52 | 6 | int:PDCD6 | |
| Interaction | DDIT3 interactions | 1.43e-05 | 120 | 52 | 5 | int:DDIT3 | |
| Interaction | MCM2 interactions | YTHDF1 HSPG2 ILF3 USP9X BAG4 SEC24B EIF4G1 PYGB EWSR1 FUS TFG EP300 | 1.50e-05 | 1081 | 52 | 12 | int:MCM2 |
| Interaction | RBMS1 interactions | 1.50e-05 | 207 | 52 | 6 | int:RBMS1 | |
| Interaction | PABPC4 interactions | 1.62e-05 | 442 | 52 | 8 | int:PABPC4 | |
| Interaction | THRAP3 interactions | 1.65e-05 | 443 | 52 | 8 | int:THRAP3 | |
| Interaction | PAX7 interactions | 1.68e-05 | 124 | 52 | 5 | int:PAX7 | |
| Interaction | SMG7 interactions | 1.69e-05 | 319 | 52 | 7 | int:SMG7 | |
| Interaction | SMAD3 interactions | 1.76e-05 | 447 | 52 | 8 | int:SMAD3 | |
| Interaction | RUNX1 interactions | 1.87e-05 | 324 | 52 | 7 | int:RUNX1 | |
| Interaction | FUS interactions | 1.99e-05 | 757 | 52 | 10 | int:FUS | |
| Interaction | R3HDM2 interactions | 2.03e-05 | 129 | 52 | 5 | int:R3HDM2 | |
| Interaction | SMARCA4 interactions | 2.23e-05 | 462 | 52 | 8 | int:SMARCA4 | |
| Interaction | DDX1 interactions | 2.26e-05 | 463 | 52 | 8 | int:DDX1 | |
| Interaction | RARA interactions | 2.28e-05 | 223 | 52 | 6 | int:RARA | |
| Interaction | PHF10 interactions | 2.91e-05 | 139 | 52 | 5 | int:PHF10 | |
| Interaction | NANOG interactions | 2.97e-05 | 481 | 52 | 8 | int:NANOG | |
| Interaction | FAM120A interactions | 3.01e-05 | 349 | 52 | 7 | int:FAM120A | |
| Interaction | VPS37C interactions | 3.12e-05 | 141 | 52 | 5 | int:VPS37C | |
| Interaction | HNRNPD interactions | 3.29e-05 | 638 | 52 | 9 | int:HNRNPD | |
| Interaction | MYCN interactions | YTHDF1 CASC3 ILF3 TIAL1 SS18L1 EWSR1 FUS ARID1A TFG SS18 CAPRIN1 EP300 SMG6 | 3.34e-05 | 1373 | 52 | 13 | int:MYCN |
| Interaction | SNRNP70 interactions | YTHDF1 CASC3 ILF3 TIAL1 USP9X RC3H1 EIF4G1 EWSR1 FUS CAPRIN1 EP300 | 3.40e-05 | 984 | 52 | 11 | int:SNRNP70 |
| Interaction | ITCH interactions | 3.42e-05 | 356 | 52 | 7 | int:ITCH | |
| Interaction | ELF5 interactions | 3.80e-05 | 147 | 52 | 5 | int:ELF5 | |
| Interaction | YTHDF3 interactions | 3.96e-05 | 246 | 52 | 6 | int:YTHDF3 | |
| Interaction | MUSK interactions | 3.97e-05 | 74 | 52 | 4 | int:MUSK | |
| Interaction | ARID2 interactions | 4.60e-05 | 153 | 52 | 5 | int:ARID2 | |
| Cytoband | 13q34 | 1.73e-03 | 54 | 52 | 2 | 13q34 | |
| Cytoband | 11p13 | 1.86e-03 | 56 | 52 | 2 | 11p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p13 | 2.50e-03 | 65 | 52 | 2 | chr11p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q34 | 4.53e-03 | 88 | 52 | 2 | chr13q34 | |
| GeneFamily | Zinc fingers RANBP2-type |RNA binding motif containing | 9.41e-06 | 21 | 36 | 3 | 89 | |
| GeneFamily | RNA binding motif containing | 6.06e-05 | 213 | 36 | 5 | 725 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 5.14e-04 | 17 | 36 | 2 | 486 | |
| GeneFamily | LIM domain containing | 6.14e-03 | 59 | 36 | 2 | 1218 | |
| GeneFamily | Basic helix-loop-helix proteins | 2.02e-02 | 110 | 36 | 2 | 420 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 7.03e-10 | 323 | 52 | 10 | M9150 | |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | HSPG2 ILF3 USP9X BAG4 SEC24B SEC23IP EIF4G1 WT1 NCOA1 TFG SS18 ERBIN CAPRIN1 | 2.43e-06 | 1399 | 52 | 13 | M535 |
| Coexpression | MATZUK_EMBRYONIC_GERM_CELL | 6.98e-06 | 19 | 52 | 3 | M1821 | |
| Coexpression | GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_4H_UP | 4.78e-05 | 200 | 52 | 5 | M8705 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_1000 | ADAMTS9 SEC24B WT1 DAZL EWSR1 FUS ZMIZ1 RUNX1T1 ARID1A ME1 CAPRIN1 | 3.73e-06 | 819 | 52 | 11 | gudmap_developingGonad_e12.5_testes_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500 | 2.08e-05 | 231 | 52 | 6 | gudmap_developingGonad_e11.5_testes and mesonephros_k4_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.63e-05 | 498 | 52 | 8 | gudmap_developingGonad_e11.5_testes_k5_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_200 | 3.95e-05 | 156 | 52 | 5 | gudmap_developingGonad_e12.5_ovary_200 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_100 | 5.09e-05 | 83 | 52 | 4 | gudmap_developingGonad_e18.5_epididymis_100 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_200 | 5.31e-05 | 166 | 52 | 5 | gudmap_developingGonad_e16.5_epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_200 | 5.31e-05 | 166 | 52 | 5 | gudmap_developingGonad_e18.5_epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_100 | 5.34e-05 | 84 | 52 | 4 | gudmap_developingGonad_e14.5_ epididymis_100 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_200 | 5.46e-05 | 167 | 52 | 5 | gudmap_developingGonad_e14.5_ epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_100 | 5.85e-05 | 86 | 52 | 4 | gudmap_developingGonad_e16.5_epididymis_100 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500 | 6.28e-05 | 172 | 52 | 5 | gudmap_developingGonad_e11.5_ovary + mesonephros_k4_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_100 | 6.53e-05 | 32 | 52 | 3 | gudmap_developingGonad_e18.5_epididymis_100_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#5_top-relative-expression-ranked_200 | 7.30e-05 | 91 | 52 | 4 | gudmap_developingGonad_e14.5_ epididymis_200_k5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | 1.02e-04 | 778 | 52 | 9 | gudmap_developingGonad_e18.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_200 | 1.28e-04 | 40 | 52 | 3 | gudmap_developingGonad_P2_epididymis_200_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500 | 1.31e-04 | 201 | 52 | 5 | gudmap_developingKidney_e15.5_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | 1.33e-04 | 806 | 52 | 9 | gudmap_developingGonad_e12.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.61e-04 | 210 | 52 | 5 | gudmap_developingGonad_e18.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000 | 1.86e-04 | 843 | 52 | 9 | gudmap_developingGonad_e11.5_testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#1_top-relative-expression-ranked_100 | 2.22e-04 | 48 | 52 | 3 | gudmap_developingGonad_e14.5_ epididymis_100_k1 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.74e-04 | 524 | 52 | 7 | gudmap_developingGonad_e12.5_testes_k1_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | 3.04e-04 | 533 | 52 | 7 | gudmap_developingGonad_e11.5_testes and mesonephros_k5_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_500 | 3.16e-04 | 379 | 52 | 6 | gudmap_developingGonad_P2_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#2_top-relative-expression-ranked_500 | 3.43e-04 | 136 | 52 | 4 | gudmap_developingGonad_P2_epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.44e-04 | 385 | 52 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_500 | 3.54e-04 | 387 | 52 | 6 | gudmap_developingGonad_e18.5_ovary_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.23e-04 | 259 | 52 | 5 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_500 | 4.33e-04 | 402 | 52 | 6 | gudmap_developingKidney_e15.5_anlage of loop of Henle_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | 4.38e-04 | 403 | 52 | 6 | gudmap_developingGonad_e12.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#2_top-relative-expression-ranked_200 | 4.51e-04 | 61 | 52 | 3 | gudmap_developingGonad_e12.5_epididymis_k2_200 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 4.56e-04 | 406 | 52 | 6 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_200 | 4.61e-04 | 147 | 52 | 4 | gudmap_developingGonad_e18.5_ovary_200 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500 | 4.98e-04 | 150 | 52 | 4 | gudmap_developingGonad_e12.5_epididymis_k5_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 4.99e-04 | 413 | 52 | 6 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_1000 | 5.10e-04 | 151 | 52 | 4 | gudmap_developingGonad_P2_ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_200 | 5.19e-04 | 64 | 52 | 3 | gudmap_developingGonad_e18.5_epididymis_200_k5 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_500 | 5.25e-04 | 417 | 52 | 6 | gudmap_developingGonad_e11.5_ovary + mesonephros_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_top-relative-expression-ranked_1000 | 5.28e-04 | 770 | 52 | 8 | gudmap_developingGonad_P2_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#2_top-relative-expression-ranked_500 | 5.44e-04 | 65 | 52 | 3 | gudmap_developingGonad_P2_ovary_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#2_top-relative-expression-ranked_200 | 5.44e-04 | 65 | 52 | 3 | gudmap_developingGonad_e12.5_ovary_k2_200 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_200 | 6.20e-04 | 159 | 52 | 4 | gudmap_developingGonad_e12.5_epididymis_200 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_100 | 6.20e-04 | 68 | 52 | 3 | gudmap_developingGonad_e12.5_ovary_100 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_500 | 6.49e-04 | 161 | 52 | 4 | gudmap_developingGonad_e12.5_ovary_k3_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_200 | 6.49e-04 | 161 | 52 | 4 | gudmap_developingGonad_e11.5_ovary + mesonephros_200 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_500 | 6.55e-04 | 435 | 52 | 6 | gudmap_developingGonad_e11.5_testes and mesonephros_500 | |
| CoexpressionAtlas | Stromal Cells, Ep.MEChi.Th, CD45- EpCAm+ Ly51- MHCIIhi, Thymus, avg-2 | 6.75e-04 | 70 | 52 | 3 | GSM777041_100 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | 7.01e-04 | 804 | 52 | 8 | gudmap_developingGonad_e12.5_ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_200 | 7.12e-04 | 165 | 52 | 4 | gudmap_developingGonad_e12.5_testes_200 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_100 | 7.63e-04 | 73 | 52 | 3 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_100 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#3_top-relative-expression-ranked_200 | 7.81e-04 | 17 | 52 | 2 | gudmap_developingGonad_e11.5_ovary + mesonephros_k3_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | 7.85e-04 | 818 | 52 | 8 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_200 | 8.58e-04 | 76 | 52 | 3 | gudmap_developingGonad_e16.5_epididymis_200_k4 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_100 | 8.58e-04 | 76 | 52 | 3 | gudmap_developingGonad_e12.5_epididymis_100 | |
| CoexpressionAtlas | Stromal Cells, Ep.MEChi.Th, CD45-EpCAm+Ly51-MHCIIhi, Thymus, avg-1 | 8.92e-04 | 77 | 52 | 3 | GSM854302_100 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_100 | 9.61e-04 | 79 | 52 | 3 | gudmap_developingGonad_e11.5_ovary + mesonephros_100 | |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_100 | 9.79e-04 | 19 | 52 | 2 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_k3_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | 9.79e-04 | 312 | 52 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_100 | 1.07e-03 | 82 | 52 | 3 | gudmap_developingGonad_e12.5_testes_100 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.14e-03 | 323 | 52 | 5 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_100 | 1.32e-03 | 22 | 52 | 2 | gudmap_developingGonad_e16.5_epididymis_100_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.45e-03 | 91 | 52 | 3 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k3_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.71e-03 | 209 | 52 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_500 | 1.74e-03 | 97 | 52 | 3 | gudmap_developingGonad_e18.5_ovary_500_k3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_200 | 1.84e-03 | 26 | 52 | 2 | gudmap_developingGonad_e18.5_ovary_200_k3 | |
| ToppCell | COVID-19-lung-Vein_EC|lung / Disease (COVID-19 only), tissue and cell type | 8.53e-08 | 188 | 52 | 6 | d582b76fc2faac526c9bf97503041129e1a6a211 | |
| ToppCell | Endothelial-endothelial_cell_of_vein|World / Lineage, Cell type, age group and donor | 1.03e-07 | 194 | 52 | 6 | 3cbd9622a68e89add90e589867d88c83c5a33476 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-07 | 195 | 52 | 6 | 5a6a5048af638872700b76b7c71a8fa3fb8d3772 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.09e-07 | 196 | 52 | 6 | 09a7edf4a7defb7fe70d9777dd9500ee8421ff31 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.09e-07 | 196 | 52 | 6 | e50d2c66d5c5cd25fdfecdcc4c8506a1d0a85755 | |
| ToppCell | Tracheal-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-07 | 198 | 52 | 6 | 77e31b6edeeb5ccd5cd3f080898c96bf9ab9f98d | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_vascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-07 | 198 | 52 | 6 | f7aa809040fa9f5782b92eec1f289d690eb5c7bd | |
| ToppCell | facs-Heart-RA-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-06 | 178 | 52 | 5 | b505e2550860e777535ee95f29c936242fd607f1 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D231|Adult / Lineage, Cell type, age group and donor | 2.05e-06 | 178 | 52 | 5 | c80ca7a2d3f976089a5e71d0cd9ba9a1c0bd2815 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.47e-06 | 185 | 52 | 5 | 94d0f283d63d932f310cc5a17ea893d71ba60f5e | |
| ToppCell | COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.61e-06 | 187 | 52 | 5 | 2d20193a6cacdfa4877457c97b0077408942186c | |
| ToppCell | COVID-19-Heart-EC_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.75e-06 | 189 | 52 | 5 | fe49852ba15f948b384d6b4c258927c70b741357 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel|Adult / Lineage, Cell type, age group and donor | 2.82e-06 | 190 | 52 | 5 | 91bf3b7e9148589757436a53a4f58e0ebfe54400 | |
| ToppCell | COVID-19-lung-Vein_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.82e-06 | 190 | 52 | 5 | 1caeaef78326734c1e31a0c4739190d5c5a77b9e | |
| ToppCell | COPD-Endothelial-Lymphatic|COPD / Disease state, Lineage and Cell class | 3.04e-06 | 193 | 52 | 5 | 18bcf08068a236c4575c7a07181ac893dfdcbeeb | |
| ToppCell | Adult-Endothelial|Adult / Lineage, Cell type, age group and donor | 3.12e-06 | 194 | 52 | 5 | 963b3fbee0575af8379baa397ace65949eaf34f7 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_immature|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.28e-06 | 196 | 52 | 5 | c65b8c7ea34a21897c390e6fb42ee8ca41e9c976 | |
| ToppCell | PCW_10-12-Endothelial|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.28e-06 | 196 | 52 | 5 | 2c60dcf9132ee156f25b349e2ac5313709def4f6 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.28e-06 | 196 | 52 | 5 | 151f1a29a91f8b234e9b6ed062666357a2f69128 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 3.36e-06 | 197 | 52 | 5 | 4961f66606f08e399508fd6cabca588e7ab406a8 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.36e-06 | 197 | 52 | 5 | b0036cf3f7e6edf8e43f16cd2f0f0e80471d2576 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-06 | 198 | 52 | 5 | 2f03f8897dd7cce6d8296638e14e11ec16bcf624 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.45e-06 | 198 | 52 | 5 | 5c82dad416938d5c460069796d808170e7dbc8d9 | |
| ToppCell | facs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-06 | 198 | 52 | 5 | f2a4057f038ef7225a5b98a7ab068c30dff4eadd | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-06 | 199 | 52 | 5 | 3a4deea6e11a0555d27497b7c9983350797aac69 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.53e-06 | 199 | 52 | 5 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-06 | 199 | 52 | 5 | 079931e7196719f22a89cfad82f452ec67219ee5 | |
| ToppCell | cellseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.62e-06 | 200 | 52 | 5 | a1f5684fe3815642159dd201b7ecc39f09bee1e8 | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.62e-06 | 200 | 52 | 5 | 35f6c7f2469d12748c27f2a5d4a161ef839b4a07 | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_lymphatic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.62e-06 | 200 | 52 | 5 | b515b2ab0c3f5928dd67f2f227fc932451c272bb | |
| ToppCell | 3'-Adult-LymphNode-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.62e-06 | 200 | 52 | 5 | 663e2b4672f193844bb9bf4873749114977c19b3 | |
| ToppCell | Tracheal-10x5prime-Endothelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.62e-06 | 200 | 52 | 5 | 71ba0e48ca4ded077f2b96a0cf4f2331f2e25d15 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.21e-05 | 166 | 52 | 4 | 8e5f2afbeffae5e77fcb29e8fe9f5aa49779b619 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.21e-05 | 166 | 52 | 4 | f7926ee266dcbf10df375cd921f1db5a2fa604f8 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.31e-05 | 167 | 52 | 4 | d7fe24cdc4b55a9555ce9e20699f5036b88148e9 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-B_(Artery)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.52e-05 | 169 | 52 | 4 | 337be3bf485b54afad86e256cb0c4c1d0c2a9a2a | |
| ToppCell | 356C-Endothelial_cells-Endothelial-B_(Artery)|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.52e-05 | 169 | 52 | 4 | 605cc2638271803cf1d972ab3fa8f13f89666376 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein-D231|Adult / Lineage, Cell type, age group and donor | 5.06e-05 | 174 | 52 | 4 | 2dd647c4fdf99fd1f7b838efef01baf2cbc3446d | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-05 | 176 | 52 | 4 | eb63eb2c301e785196ccadac74a2940b2c524c62 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.65e-05 | 179 | 52 | 4 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.16e-05 | 183 | 52 | 4 | a644258ba90acc62d571623e429d72ffc4b69203 | |
| ToppCell | Control-Endothelial_cells-Pulmonary_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 6.16e-05 | 183 | 52 | 4 | 46be9f96755c7b65aeac061d95d15abeb6466034 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.42e-05 | 185 | 52 | 4 | 0ab1be455f2cd883c9d1522ca78112c37833352e | |
| ToppCell | Endothelial-A-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 6.42e-05 | 185 | 52 | 4 | dee0b7ba2f338f0979d2306aedf52ac35a36b60c | |
| ToppCell | 3'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.42e-05 | 185 | 52 | 4 | fa94c4a1660967f211ba095606cd0aa37d38e17a | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 6.56e-05 | 186 | 52 | 4 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.69e-05 | 187 | 52 | 4 | e35716f8b482be3bf5ab79f087a9caf67a9d197a | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.83e-05 | 188 | 52 | 4 | bd091503f580dedab40e0996273101285d24b586 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 6.83e-05 | 188 | 52 | 4 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | facs-Heart-LV-18m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.83e-05 | 188 | 52 | 4 | e5a8ca4613ab0bf1584b9e78959adf41d0bf379f | |
| ToppCell | facs-Heart-LV-18m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.83e-05 | 188 | 52 | 4 | ed11e26ff4ef3d6314b5f5734062519b9aa285c1 | |
| ToppCell | facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.83e-05 | 188 | 52 | 4 | 6ab5ce8569f896a0fe7a76b8b4a83661e5499b8c | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 6.83e-05 | 188 | 52 | 4 | b66f1f08827dd6c48583d871f9f33ea41e48bfb2 | |
| ToppCell | facs-Heart-LV-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.83e-05 | 188 | 52 | 4 | 0fc3a6562e6895f6fe7a93397eae842a75c60c93 | |
| ToppCell | Endothelial-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 6.83e-05 | 188 | 52 | 4 | 0824d567356d360fd8e78e840c30529c139f98a1 | |
| ToppCell | facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.83e-05 | 188 | 52 | 4 | 20072a2a3f9ecbe727c850629f19420cf60e4bc5 | |
| ToppCell | facs-Trachea-3m-Endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.83e-05 | 188 | 52 | 4 | dd817059e1b4225e84733559f7839cc973b7dfd6 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.83e-05 | 188 | 52 | 4 | c2805232618a7b6f844d34e37ad458a9923dbfe1 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.83e-05 | 188 | 52 | 4 | aeecbc057dc823f8fcea8a98f18d213bacc7f4db | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.98e-05 | 189 | 52 | 4 | e830fa0ddc3dccfaf9e88e8c416ed6aab12e3e3f | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.98e-05 | 189 | 52 | 4 | fccadf8efbef17b7f12291b069c71060a71b04e2 | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.98e-05 | 189 | 52 | 4 | ecbe079606406f47d4fc97fe1670790dda8e10de | |
| ToppCell | facs-Trachea-nan-3m-Endothelial-endothelial_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-05 | 189 | 52 | 4 | e3d65417997bdd3f9c312c0977dceb6eca061029 | |
| ToppCell | facs-Trachea-18m-Endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.98e-05 | 189 | 52 | 4 | f635f3f13bced3bcf796cf55723a2df851f973fe | |
| ToppCell | facs-Trachea-nan-3m-Endothelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-05 | 189 | 52 | 4 | 5559af03d9d612bb8dcf825e45744a9f8332bac8 | |
| ToppCell | facs-Trachea-nan-3m-Endothelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-05 | 189 | 52 | 4 | f60ac60ab9b317a0196f0cbbe520ef7dbd19ac11 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.12e-05 | 190 | 52 | 4 | 141266bf411ea675fbf889b20c1b08673c45ff95 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.12e-05 | 190 | 52 | 4 | 6e6ce6dd549d1c38cfef5b3f8be06ab01ce344b7 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 190 | 52 | 4 | b7fc451e160e31dc898b122de844b501f587db67 | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 190 | 52 | 4 | bb1476b44dd49e1dd52a636a91c4600b6d4fbe2e | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 190 | 52 | 4 | d180205c70b5ca9bc5a01a2e6cb42fcebc7f630d | |
| ToppCell | 343B-Endothelial_cells-Endothelial-A_(Artery)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.12e-05 | 190 | 52 | 4 | ac2eb1e51459d187095152e0cd41ae54c1025c6f | |
| ToppCell | facs-Pancreas-Exocrine-3m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 190 | 52 | 4 | 83cc851fb9f644b17a8ebf4d99a646003769a22f | |
| ToppCell | 343B-Endothelial_cells-Endothelial-A_(Artery)|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.12e-05 | 190 | 52 | 4 | 6010f16378f2d9cde37c7e7db6a7d9666edaddcc | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-endothelial_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 190 | 52 | 4 | 38a815abf0ac5cac6071737cadc54a514f62d37d | |
| ToppCell | facs-Pancreas-Exocrine-3m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.12e-05 | 190 | 52 | 4 | 5f440d4b334d66d419c03bd828f7d93f16c1ce67 | |
| ToppCell | facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.12e-05 | 190 | 52 | 4 | 2655df8c0883dd811fa7617301f9c4b0a4dd55ec | |
| ToppCell | Endothelial-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 7.27e-05 | 191 | 52 | 4 | f702dfe88a9b04091dae87df61b2b4f43525f86a | |
| ToppCell | Control-Endothelial-VE_Venous|Control / Disease state, Lineage and Cell class | 7.27e-05 | 191 | 52 | 4 | 617546cf4883dedf3323e03a53ba5adec334cf8e | |
| ToppCell | facs-SCAT-Fat-3m-Endothelial-nan|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 191 | 52 | 4 | a0018f88f7132477cc467ee15db029a585290595 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_postreplicative-neuro_neuronal_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.27e-05 | 191 | 52 | 4 | 3a5081dc542ac6262acfe5f8084a86616fee8082 | |
| ToppCell | facs-Heart-LA-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 191 | 52 | 4 | 827be47d3574c6c5b021c6f1c1670834344f10cb | |
| ToppCell | facs-SCAT-Fat-3m-Endothelial-endothelial_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 191 | 52 | 4 | 6b9bbf4a63d4e9a8075bb06c2aa644fcf4ee88b8 | |
| ToppCell | facs-Heart-LA-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 191 | 52 | 4 | a15f0fb4bd7dd77ef5f931b6fc9d68697deec1d1 | |
| ToppCell | facs-SCAT-Fat-3m-Endothelial|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 191 | 52 | 4 | 90f0c193dce267a4f1a9b2501f636dafd0a34cf7 | |
| ToppCell | droplet-Heart|droplet / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-05 | 192 | 52 | 4 | 67a7e07a11091120edbccf739836235c422ec9c6 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Endothelial-endothelial_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-05 | 192 | 52 | 4 | 0986b7900021efe2a4df84a935e7c9a0af1b0e57 | |
| ToppCell | droplet-Heart-HEART-1m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-05 | 192 | 52 | 4 | 9da21ce330f3b5661f159cf18d1c3e5ccc11d6dd | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Endothelial-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-05 | 192 | 52 | 4 | 8f20d3511dcb44445592b17d005a53da0052ae56 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 7.41e-05 | 192 | 52 | 4 | 6c106b91e46eabbe686a52a65a9c94ad9cbe9390 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m-Endothelial|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-05 | 192 | 52 | 4 | b28d294e42b303d1db6060231d84d7b9e4d9fccf | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-05 | 192 | 52 | 4 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.41e-05 | 192 | 52 | 4 | 28eb3a5728e8901bcb5ba12f6b009f41b065fa37 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.56e-05 | 193 | 52 | 4 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.56e-05 | 193 | 52 | 4 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.56e-05 | 193 | 52 | 4 | 6a623acd1adad9a78eddc32ffedb16352ad3fdfa | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.56e-05 | 193 | 52 | 4 | c0973a2c97deb7176c2f617c8760a55f7edc9839 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_immature-endo_immature4_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.56e-05 | 193 | 52 | 4 | 01c71aa48875b5ad6c50cc810a72862e72f26ad0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.56e-05 | 193 | 52 | 4 | 0b328f725f6feba263783eaca60c142e80df90f3 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature-endo_venous_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.56e-05 | 193 | 52 | 4 | 84d1c1b7d3a1cb80f175527e3c89a2c3da7657f7 | |
| Drug | A-skin | 9.12e-11 | 32 | 52 | 6 | CID000208772 | |
| Drug | 16, 16-dimethylprostaglandin E2 methyl acetate solution; Down 200; 10uM; PC3; HT_HG-U133A | 5.52e-06 | 196 | 52 | 6 | 6562_DN | |
| Drug | Ethoxyquin [91-53-2]; Up 200; 18.4uM; PC3; HT_HG-U133A | 5.52e-06 | 196 | 52 | 6 | 4321_UP | |
| Drug | ifosfamide | 1.67e-05 | 67 | 52 | 4 | CID000003690 | |
| Drug | vinylene | 1.96e-05 | 245 | 52 | 6 | CID000006326 | |
| Drug | telomestatin | 2.81e-05 | 26 | 52 | 3 | CID000443590 | |
| Drug | 2d41 | 3.16e-05 | 27 | 52 | 3 | CID009543496 | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 4.40e-05 | 171 | 52 | 5 | 7535_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 4.65e-05 | 173 | 52 | 5 | 4237_DN | |
| Drug | 14-deoxy-11,12-didehydroandrographolide | 4.91e-05 | 175 | 52 | 5 | ctd:C495626 | |
| Drug | imatinib | 5.25e-05 | 430 | 52 | 7 | CID000005291 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 5.47e-05 | 179 | 52 | 5 | 6609_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 5.62e-05 | 180 | 52 | 5 | 6886_DN | |
| Drug | EMCs | 6.40e-05 | 34 | 52 | 3 | CID005091655 | |
| Drug | AC1L2E0P | 6.92e-05 | 307 | 52 | 6 | CID000019390 | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 7.44e-05 | 191 | 52 | 5 | 7503_DN | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 1uM; PC3; HT_HG-U133A | 7.63e-05 | 192 | 52 | 5 | 4334_DN | |
| Drug | Lidocaone hydrochloride [73-78-9]; Down 200; 14.8uM; PC3; HT_HG-U133A | 7.82e-05 | 193 | 52 | 5 | 4596_DN | |
| Drug | Carbetapentane citrate [23142-01-0]; Down 200; 7.6uM; HL60; HT_HG-U133A | 7.82e-05 | 193 | 52 | 5 | 1268_DN | |
| Drug | Rolipram [61413-54-5]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 8.01e-05 | 194 | 52 | 5 | 5330_DN | |
| Drug | Minaprine dihydrochloride [25953-17-7]; Down 200; 10.8uM; HL60; HG-U133A | 8.21e-05 | 195 | 52 | 5 | 1968_DN | |
| Drug | Isoxsuprine hydrochloride [579-56-6]; Down 200; 11.8uM; HL60; HG-U133A | 8.21e-05 | 195 | 52 | 5 | 1985_DN | |
| Drug | Metrizamide [31112-62-6]; Up 200; 5uM; HL60; HT_HG-U133A | 8.21e-05 | 195 | 52 | 5 | 1318_UP | |
| Drug | Diperodon hydrochloride [537-12-2]; Up 200; 9.2uM; HL60; HG-U133A | 8.21e-05 | 195 | 52 | 5 | 1575_UP | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; HL60; HT_HG-U133A | 8.41e-05 | 196 | 52 | 5 | 1326_UP | |
| Drug | Beta-Escin [11072-93-8]; Down 200; 3.2uM; PC3; HT_HG-U133A | 8.61e-05 | 197 | 52 | 5 | 4544_DN | |
| Drug | Minoxidil [38304-91-5]; Down 200; 19.2uM; PC3; HT_HG-U133A | 8.61e-05 | 197 | 52 | 5 | 4216_DN | |
| Drug | Piperacillin sodium salt [59703-84-3]; Up 200; 7.4uM; PC3; HT_HG-U133A | 8.82e-05 | 198 | 52 | 5 | 4320_UP | |
| Drug | Flucytosine [2022-85-7]; Up 200; 31uM; MCF7; HT_HG-U133A | 8.82e-05 | 198 | 52 | 5 | 5289_UP | |
| Drug | aspirin, USP; Down 200; 100uM; MCF7; HT_HG-U133A_EA | 8.82e-05 | 198 | 52 | 5 | 1042_DN | |
| Drug | Sc 356 | 1.07e-04 | 7 | 52 | 2 | CID000022975 | |
| Drug | CV-1 | 1.24e-04 | 213 | 52 | 5 | CID000130105 | |
| Drug | P-15 | 1.51e-04 | 222 | 52 | 5 | CID000200884 | |
| Drug | AC1L1G5B | 1.59e-04 | 46 | 52 | 3 | CID000003531 | |
| Drug | pSer | 1.97e-04 | 126 | 52 | 4 | CID000000106 | |
| Drug | Nor 3 | 2.04e-04 | 50 | 52 | 3 | CID009578441 | |
| Disease | Desmoplastic Small Round Cell Tumor | 3.05e-06 | 2 | 52 | 2 | C0281508 | |
| Disease | amyotrophic lateral sclerosis type 6 (implicated_via_orthology) | 9.13e-06 | 3 | 52 | 2 | DOID:0060198 (implicated_via_orthology) | |
| Disease | Leukemia, Myelocytic, Acute | 1.36e-05 | 173 | 52 | 5 | C0023467 | |
| Disease | Extra-osseous Ewing's sarcoma | 1.82e-05 | 4 | 52 | 2 | C0279980 | |
| Disease | Adenoid Cystic Carcinoma | 2.97e-05 | 100 | 52 | 4 | C0010606 | |
| Disease | Extraskeletal Myxoid Chondrosarcoma | 3.04e-05 | 5 | 52 | 2 | C1275278 | |
| Disease | Ewings sarcoma | 8.47e-05 | 8 | 52 | 2 | C0553580 | |
| Disease | frontotemporal dementia (implicated_via_orthology) | 1.99e-04 | 12 | 52 | 2 | DOID:9255 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | 2.21e-04 | 702 | 52 | 7 | C0009402 | |
| Disease | stomach cancer (is_implicated_in) | 2.83e-04 | 72 | 52 | 3 | DOID:10534 (is_implicated_in) | |
| Disease | monocyte percentage of leukocytes | 2.83e-04 | 731 | 52 | 7 | EFO_0007989 | |
| Disease | T-Cell Lymphoma | 3.60e-04 | 16 | 52 | 2 | C0079772 | |
| Disease | age of onset of asthma | 3.71e-04 | 79 | 52 | 3 | OBA_2001001 | |
| Disease | breast carcinoma | 3.84e-04 | 1019 | 52 | 8 | EFO_0000305 | |
| Disease | neoplasm of mature B-cells | 5.67e-04 | 20 | 52 | 2 | EFO_0000096 | |
| Disease | Vitiligo | 7.62e-04 | 101 | 52 | 3 | EFO_0004208 | |
| Disease | Sezary Syndrome | 1.04e-03 | 27 | 52 | 2 | C0036920 | |
| Disease | intelligence, response to cranial radiation therapy | 1.12e-03 | 28 | 52 | 2 | EFO_0004337, EFO_0010950 | |
| Disease | Bilateral Wilms Tumor | 1.20e-03 | 29 | 52 | 2 | C2930471 | |
| Disease | amyotrophic lateral sclerosis (implicated_via_orthology) | 1.28e-03 | 30 | 52 | 2 | DOID:332 (implicated_via_orthology) | |
| Disease | waist-hip ratio | 1.28e-03 | 1226 | 52 | 8 | EFO_0004343 | |
| Disease | vital capacity | 1.35e-03 | 1236 | 52 | 8 | EFO_0004312 | |
| Disease | Acute Myeloid Leukemia, M1 | 1.41e-03 | 125 | 52 | 3 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 1.41e-03 | 125 | 52 | 3 | C1879321 | |
| Disease | Colorectal Neoplasms | 1.44e-03 | 277 | 52 | 4 | C0009404 | |
| Disease | testosterone measurement | 1.65e-03 | 1275 | 52 | 8 | EFO_0004908 | |
| Disease | glomerular filtration rate, renal transplant outcome measurement | 1.75e-03 | 35 | 52 | 2 | EFO_0005199, EFO_0005208 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GGSHQEQPPYPSYNS | 86 | O95429 | |
| SYGQQPPTSYPPQTG | 231 | Q01844 | |
| NPLQYPVGPTNGVYP | 526 | Q86US8 | |
| QSAPQIYGPPQYNIQ | 966 | Q96RT1 | |
| NPYGSPYTQNPGQQI | 251 | Q09472 | |
| PYQQNPYNPRGSSNV | 6 | O94929 | |
| LYPPGSLPQGAQYNI | 261 | Q00973 | |
| TAPYSYVGQKPPNTQ | 21 | Q6NVV7 | |
| GQPLQVKYYPPNGTF | 211 | P51164 | |
| PAYPNSPVQVTTGYQ | 361 | Q9NR90 | |
| YPNSPVQVTTGYQLP | 411 | Q9NR90 | |
| PQQNTGFPRSNQPYY | 591 | Q14444 | |
| VNSQYGTQPQQYPPI | 651 | Q5TC82 | |
| PGYYGNPSQGQPCQR | 1251 | P98160 | |
| LSTYSQQPGTLGYPQ | 781 | Q99743 | |
| RPQPYGGTNPYSQQQ | 391 | O14497 | |
| YSQQQGPPSGPQQGH | 401 | O14497 | |
| PQQGHGYPGQPYGSQ | 411 | O14497 | |
| SYTQQIPPYGQQGPS | 446 | O14497 | |
| IPPYGQQGPSGYGQQ | 451 | O14497 | |
| QQGPSGYGQQGQTPY | 456 | O14497 | |
| GQTPYYNQQSPHPQQ | 466 | O14497 | |
| QGGYPRQPNYNALPN | 806 | O14497 | |
| TLYPGQGNNSYVFPG | 446 | P48163 | |
| YSPNNGLSYQPNGLP | 276 | Q06455 | |
| PGQGYSQQSSQPYGQ | 21 | P35637 | |
| PNPYYCQVGLGPAQS | 481 | P29376 | |
| GQIYGSGPQGYNTQP | 241 | Q93052 | |
| EVPAGTQPPQQQYYL | 231 | Q96KN4 | |
| YSYQTTINCPGTQPP | 1651 | Q9P2N4 | |
| YPNTQAPSQVYGGVT | 651 | O15234 | |
| QYWTSPTGGIYPNPN | 421 | Q01543 | |
| QSPYSNYGPPQGKQK | 761 | Q12906 | |
| STYVVPTQQYPVQPG | 111 | Q04637 | |
| PTQQYPVQPGAPGFY | 116 | Q04637 | |
| PQGLYPNYLNPSSGQ | 386 | P33908 | |
| PDQKGNQPYYSNTPA | 801 | Q9NRM1 | |
| YPNSPVQVITGYQLP | 171 | Q92904 | |
| VQPSNPVYSGFQQYP | 481 | O95487 | |
| APLYPHSPGSQYQQN | 2496 | Q93008 | |
| HPYQQGPPSYQKQGS | 331 | Q8N5C8 | |
| YGPAVPPQTLYNPAQ | 231 | Q8WV15 | |
| QGAPQQFPYPPNYGT | 1161 | Q15788 | |
| PDYNPYQGVSVPLQQ | 76 | P13521 | |
| PGQQVGASQFPQGYQ | 71 | Q9ULP0 | |
| GYPDPSSPQVNPQYN | 861 | O00267 | |
| SYFGNQPQGIPQPGY | 166 | Q9Y6Y8 | |
| GSAQGAPSQYPGYQQ | 346 | O75177 | |
| GVQPQQPPYTGAQTQ | 221 | Q92734 | |
| PPQQPQQYGIQYSAS | 261 | Q92734 | |
| PQQGPPQQYSGQEDY | 256 | Q15532 | |
| QQQDAYQGPPPQQGY | 331 | Q15532 | |
| GALQPSPQQLYGGYQ | 131 | Q96RF0 | |
| PYDTPVPGYKNNTVN | 226 | P11216 | |
| GSLGEQQYSVPPPVY | 186 | P19544 | |
| IYQPTQAYTPASPQP | 66 | Q969M3 | |
| QTVVPQNTYPAGGNP | 326 | Q96IT1 | |
| NPYPGLLNQNTQYPS | 1616 | Q6N021 | |
| VPPYGVYGQPWNQQG | 316 | Q01085 | |
| QQYGPNSQFPTQPGQ | 416 | Q9ULJ6 | |
| PPIPYLTTYGQLSNG | 81 | Q9BYJ9 | |
| YQQVPQQPHPGFTGG | 201 | Q96PN7 | |
| IPQYGYRNNVPTTTP | 616 | Q9UL68 |